(Press-News.org) **Note: the release below is from the ESCMID Global Congress (formerly ECCMID, Barcelona, Spain, 27-30 April). Please credit the congress if you use this story**
New research presented at the ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April) has found substantial levels of resistance to critically important antibiotics in meat sold for human and animal consumption. The study is by Dr Jordan Sealey, Professor Matthew Avison and colleagues from the University of Bristol, UK.
Meat sold for consumption by humans and companion animals in the UK is regulated by the UK Government Food Standards Agency (FSA) to ensure it falls within bacterial limits deemed safe. However, while meat is tested for the types and amounts of pathogens present, it is not tested for resistant opportunistic pathogens (e.g. Escherichia coli).
Multiple studies have shown a strong association between feeding dogs a diet of uncooked meat (raw dog food) and an increased risk of excreting E. coli resistant to critically important antibiotics in their faeces. It is possible that pet animals eating raw meat increases the risk of spreading resistant pathogens to their human owners in the household. Here, the authors investigated 58 samples of uncooked meat (15 each of beef, chicken, lamb and 13 of pork) sold for human consumption after cooking (MHC) and 15 samples of chicken-based raw dog meat (RDM) for resistant E. coli.
Samples were enriched and plated onto agar containing common antibiotics - amoxicillin, amoxicillin-clavulanate, cefotaxime, ciprofloxacin, spectinomycin and streptomycin, of which some are considered critically important for human health, to test for resistant E. coli.
The team found the highest sample-level positivity rate for resistant E. coli in uncooked meat for human consumption was in chicken - 100% of samples were positive for resistance to spectinomycin and streptomycin, and 47% of samples positive for resistant to critically important fluoroquinolones. For lamb, pork and beef the values were 27%, 38% and 27% for spectinomycin, 40%, 38% and 47% for streptomycin and 7%, 8% and 13% for fluoroquinolones, respectively.
Similar levels of resistance were seen in chicken raw dog food samples as seen in chicken meat; 87% positive for spectinomycin and streptomycin resistance, and 47% for fluoroquinolones. Sample level positivity for resistance to critically important cefotaxime was 27% for raw dog food. The authors say: “While most people know that if they don’t use proper hygiene when handling uncooked meat they can pick up ‘food poisoning’, most people are not aware that you can also pick up antibiotic-resistant opportunistic pathogens. Owners who feed their dogs raw dog food perhaps don’t realise this uncooked meat also contains these pathogens and maybe don’t use proper hygiene after preparing the meat, and don’t consider their dog as a potential source of these pathogens if it is raw fed.”
The most common STs in raw dog food were ST10, ST162, ST744 – in the authors’ previous study on fluoroquinolone resistance in dogs, excretion of these STs was found to be strongly associated with dogs being fed a raw food diet.
The authors conclude: “This study confirms that uncooked meat carries multiple resistant E. coli, commonly including resistance to critically important antibiotics important for human health. If ingested, these bacteria can enter the gut, and may cause resistant opportunistic infections (e.g. urinary tract infections) in the future. It is therefore very important that people cook meat thoroughly before eating, and use appropriate hygiene practices during meat preparation. Our findings that raw dog food is similarly contaminated with resistant bacteria provides an explanation for why dogs fed raw meat are more likely to excrete these bacteria. Appropriate hygiene practises after handling raw dog food, and dogs that are fed such raw meat, are strongly advised.”
END
Study finds resistance to critically important antibiotics in uncooked meat sold for human and animal consumption
2024-04-29
ELSE PRESS RELEASES FROM THIS DATE:
Global cervical cancer vaccine roll-out shows it to be very effective in reducing cervical cancer and other HPV-related disease, but huge variations between countries in coverage
2024-04-28
With the creation of safe and efficacious vaccines to target human papillomavirus in the first decade of this century, WHO has an ambitious target to lower cervical cancer incidence (mostly caused by HPV) and mortality by 30% by 2030, meaning each country has a target of vaccinating 90% of girls by age 15, 70% of women receiving a high precision screening test at least at age 35 and 45 years of age, and 90% of all women requiring treatment at any age to receive it. The targets are aspirational and as yet, it appears no country has been ...
Negativity about vaccines surged on Twitter after COVID-19 jabs become available
2024-04-28
It’s time to take a new approach to addressing negative messaging about vaccines, including avoiding the use of the term “anti-vaxxers”, say the researchers.
**ECCMID has now changed name to ESCMID Global, please credit ESCMID Global Congress in all future stories**
There was a marked increase in negativity about vaccines on Twitter after COVID-19 vaccines became available, the ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April) will hear.
The analysis also found that spikes in the number of negative tweets coincided with announcements ...
Global measles cases almost double in a year
2024-04-28
Provisional global total of 321,582 cases for 2023 is almost double (88% higher) than 2022 figure of 171,153
**ECCMID has now changed name to ESCMID Global, please credit ESCMID Global Congress in all future stories**
Measles outbreaks are still occurring and in some cases increasing, among a wide variety of countries, raising concerns of an acceleration similar to just before the COVID pandemic. Dr Patrick O’Connor, of WHO Headquarters, Geneva, Switzerland will give an overview of the global measles situation at this year’s ...
Lower dose of mpox vaccine is safe and generates six-week antibody response equivalent to standard regimen
2024-04-27
WHAT:
A dose-sparing intradermal mpox vaccination regimen was safe and generated an antibody response equivalent to that induced by the standard regimen at six weeks (two weeks after the second dose), according to findings presented today at the European Society of Clinical Microbiology and Infectious Diseases Global Congress in Barcelona. The results suggest that antibody responses contributed to the effectiveness of dose-sparing mpox vaccine regimens used during the 2022 U.S. outbreak.
The ...
Personalised “cocktails” of antibiotics, probiotics and prebiotics hold great promise in treating a common form of irritable bowel syndrome, pilot study finds
2024-04-27
Personalised “cocktails” of antibiotics, probiotics and prebiotics hold great promise in the treatment of a common form of irritable bowel syndrome (IBS), the ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April) will hear.
Post-infection IBS (PI-IBS) is a form of irritable bowel syndrome that occurs after gastroenteritis or food poisoning.
Lead researcher Professor Maurizio Sanguinetti, of the Università Cattolica del Sacro Cuore, Rome, Italy, says: “Estimates vary, but research ...
Experts developing immune-enhancing therapies to target tuberculosis
2024-04-27
Some immune-enhancing therapies already exist, and their use could be investigated while other immunomodulatory drugs specific to different sub-groups of TB disease are being developed
Experts are working on novel immune-enhancing therapies called host-directed therapies to use the body’s own immune system to target tuberculosis, with hopes that they could tackle even the drug-resistant forms of the disease. In a presentation at this year’s ESCMID Global Congress (formerly ECCMID) in Barcelona (27-30 April), Associate Professor Susanna Brighenti, Center for Infectious Medicine (CIM), ANA Futura at the Karolinska ...
Making transfusion-transmitted malaria in Europe a thing of the past
2024-04-27
Individuals requiring blood transfusion are a vulnerable population, often with debilitating conditions like cancer, and transfusion-transmitted malaria is often fatal.
Current serological tests used to identify “at risk” donors are not sensitive enough to completely eliminate malaria transfusion risk.
The current challenges are to optimise the testing strategy to minimise the loss of blood products (especially those rare blood phenotypes) and to enhance screening sensitivity for infectious immuno-tolerant donors who are difficult to identify.
**ECCMID has now changed its name to ESCMID Global, please credit ...
Experts developing way to harness Nobel Prize winning CRISPR technology to deal with antimicrobial resistance (AMR)
2024-04-27
**ECCMID has now changed its name to ESCMID Global, please credit ESCMID Global Congress (formerly ECCMID, Barcelona, Spain, 27-30 April) in all future stories**
Antimicrobial resistance (AMR) is continuing to increase globally, with rates of AMR in most pathogens increasing and threatening a future in which every day medical procedures may no longer be possible and infections thought long dealt with could kill regularly again. As such, new tools to battle AMR are vitally needed.
In a new research review at this year’s ESCMID Global Congress (formerly ECCMID – Barcelona 27-30 April) shows ...
CRISPR is promising to tackle antimicrobial resistance, but remember bacteria can fight back
2024-04-27
In the second new research review on this subject, Assistant Prof. Ibrahim Bitar, Department of Microbiology, Faculty of Medicine and University Hospital in Plzen, Charles University in Prague, Plzen, Czech Republic, will give an overview of the molecular biology of CRISPR technology in explaining how it can used to tackle antimicrobial resistance.
Clustered regularly interspaced short palindromic repeats (CRISPRs) and CRISPR associated genes (cas) are widespread in the genome of many bacteria and are a defence mechanism against foreign ...
Ancient Maya blessed their ballcourts
2024-04-26
For sports fans, places like Fenway Park, Wembley Stadium or Wimbledon's Centre Court are practically hallowed ground.
Archaeologists at the University of Cincinnati found evidence of similar reverence at ballcourts built by the ancient Maya in Mexico.
Using environmental DNA analysis, researchers were able to identify a collection of plants used in ceremonial rituals in the ancient Maya city of Yaxnohcah. The plants, known for their religious associations and medicinal properties, were discovered beneath a plaza floor upon which a ballcourt was built.
Researchers said the ancient Maya likely made a ceremonial offering ...